世界のシムリン（プラムリンチド）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Symlin (pramlintide) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6028 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、シムリン（プラムリンチド）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1.5mlペンインジェクター、2.7mlペンインジェクター）、用途別市場規模（I型糖尿病、II型糖尿病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・シムリン（プラムリンチド）の市場動向 ・企業の競争状況、市場シェア ・シムリン（プラムリンチド）の種類別市場規模と予測2016-2027（1.5mlペンインジェクター、2.7mlペンインジェクター） ・シムリン（プラムリンチド）の用途別市場規模と予測2016-2027（I型糖尿病、II型糖尿病） ・シムリン（プラムリンチド）の北米市場規模2016-2027（アメリカ、カナダ） ・シムリン（プラムリンチド）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・シムリン（プラムリンチド）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・シムリン（プラムリンチド）の中南米市場規模2016-2027（メキシコ、ブラジル） ・シムリン（プラムリンチド）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca） ・結論

SYMLIN® (pramlintide acetate) injection is an anti-diabetic medication for use in patients with diabetes treated with insulin.

Market Analysis and Insights: Global Symlin (pramlintide) Market
The global Symlin (pramlintide) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Symlin (pramlintide) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Symlin (pramlintide) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Symlin (pramlintide) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Symlin (pramlintide) market.

Global Symlin (pramlintide) Scope and Market Size
Symlin (pramlintide) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Symlin (pramlintide) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
1.5ml pen-injector
2.7ml pen-injector

Segment by Application
Type I diabetes
Type II diabetes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Symlin (pramlintide) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 1.5ml pen-injector
1.2.3 2.7ml pen-injector
1.3 Market by Application
1.3.1 Global Symlin (pramlintide) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type I diabetes
1.3.3 Type II diabetes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Symlin (pramlintide) Market Perspective (2016-2027)
2.2 Symlin (pramlintide) Growth Trends by Regions
2.2.1 Symlin (pramlintide) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Symlin (pramlintide) Historic Market Share by Regions (2016-2021)
2.2.3 Symlin (pramlintide) Forecasted Market Size by Regions (2022-2027)
2.3 Symlin (pramlintide) Industry Dynamic
2.3.1 Symlin (pramlintide) Market Trends
2.3.2 Symlin (pramlintide) Market Drivers
2.3.3 Symlin (pramlintide) Market Challenges
2.3.4 Symlin (pramlintide) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Symlin (pramlintide) Players by Revenue
3.1.1 Global Top Symlin (pramlintide) Players by Revenue (2016-2021)
3.1.2 Global Symlin (pramlintide) Revenue Market Share by Players (2016-2021)
3.2 Global Symlin (pramlintide) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Symlin (pramlintide) Revenue
3.4 Global Symlin (pramlintide) Market Concentration Ratio
3.4.1 Global Symlin (pramlintide) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Symlin (pramlintide) Revenue in 2020
3.5 Symlin (pramlintide) Key Players Head office and Area Served
3.6 Key Players Symlin (pramlintide) Product Solution and Service
3.7 Date of Enter into Symlin (pramlintide) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Symlin (pramlintide) Breakdown Data by Type
4.1 Global Symlin (pramlintide) Historic Market Size by Type (2016-2021)
4.2 Global Symlin (pramlintide) Forecasted Market Size by Type (2022-2027)

5 Symlin (pramlintide) Breakdown Data by Application
5.1 Global Symlin (pramlintide) Historic Market Size by Application (2016-2021)
5.2 Global Symlin (pramlintide) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Symlin (pramlintide) Market Size (2016-2027)
6.2 North America Symlin (pramlintide) Market Size by Type
6.2.1 North America Symlin (pramlintide) Market Size by Type (2016-2021)
6.2.2 North America Symlin (pramlintide) Market Size by Type (2022-2027)
6.2.3 North America Symlin (pramlintide) Market Size by Type (2016-2027)
6.3 North America Symlin (pramlintide) Market Size by Application
6.3.1 North America Symlin (pramlintide) Market Size by Application (2016-2021)
6.3.2 North America Symlin (pramlintide) Market Size by Application (2022-2027)
6.3.3 North America Symlin (pramlintide) Market Size by Application (2016-2027)
6.4 North America Symlin (pramlintide) Market Size by Country
6.4.1 North America Symlin (pramlintide) Market Size by Country (2016-2021)
6.4.2 North America Symlin (pramlintide) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Symlin (pramlintide) Market Size (2016-2027)
7.2 Europe Symlin (pramlintide) Market Size by Type
7.2.1 Europe Symlin (pramlintide) Market Size by Type (2016-2021)
7.2.2 Europe Symlin (pramlintide) Market Size by Type (2022-2027)
7.2.3 Europe Symlin (pramlintide) Market Size by Type (2016-2027)
7.3 Europe Symlin (pramlintide) Market Size by Application
7.3.1 Europe Symlin (pramlintide) Market Size by Application (2016-2021)
7.3.2 Europe Symlin (pramlintide) Market Size by Application (2022-2027)
7.3.3 Europe Symlin (pramlintide) Market Size by Application (2016-2027)
7.4 Europe Symlin (pramlintide) Market Size by Country
7.4.1 Europe Symlin (pramlintide) Market Size by Country (2016-2021)
7.4.2 Europe Symlin (pramlintide) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Symlin (pramlintide) Market Size (2016-2027)
8.2 Asia-Pacific Symlin (pramlintide) Market Size by Type
8.2.1 Asia-Pacific Symlin (pramlintide) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Symlin (pramlintide) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Symlin (pramlintide) Market Size by Type (2016-2027)
8.3 Asia-Pacific Symlin (pramlintide) Market Size by Application
8.3.1 Asia-Pacific Symlin (pramlintide) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Symlin (pramlintide) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Symlin (pramlintide) Market Size by Application (2016-2027)
8.4 Asia-Pacific Symlin (pramlintide) Market Size by Region
8.4.1 Asia-Pacific Symlin (pramlintide) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Symlin (pramlintide) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Symlin (pramlintide) Market Size (2016-2027)
9.2 Latin America Symlin (pramlintide) Market Size by Type
9.2.1 Latin America Symlin (pramlintide) Market Size by Type (2016-2021)
9.2.2 Latin America Symlin (pramlintide) Market Size by Type (2022-2027)
9.2.3 Latin America Symlin (pramlintide) Market Size by Type (2016-2027)
9.3 Latin America Symlin (pramlintide) Market Size by Application
9.3.1 Latin America Symlin (pramlintide) Market Size by Application (2016-2021)
9.3.2 Latin America Symlin (pramlintide) Market Size by Application (2022-2027)
9.3.3 Latin America Symlin (pramlintide) Market Size by Application (2016-2027)
9.4 Latin America Symlin (pramlintide) Market Size by Country
9.4.1 Latin America Symlin (pramlintide) Market Size by Country (2016-2021)
9.4.2 Latin America Symlin (pramlintide) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Symlin (pramlintide) Market Size (2016-2027)
10.2 Middle East & Africa Symlin (pramlintide) Market Size by Type
10.2.1 Middle East & Africa Symlin (pramlintide) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Symlin (pramlintide) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Symlin (pramlintide) Market Size by Type (2016-2027)
10.3 Middle East & Africa Symlin (pramlintide) Market Size by Application
10.3.1 Middle East & Africa Symlin (pramlintide) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Symlin (pramlintide) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Symlin (pramlintide) Market Size by Application (2016-2027)
10.4 Middle East & Africa Symlin (pramlintide) Market Size by Country
10.4.1 Middle East & Africa Symlin (pramlintide) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Symlin (pramlintide) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Symlin (pramlintide) Introduction
11.1.4 AstraZeneca Revenue in Symlin (pramlintide) Business (2016-2021)
11.1.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Symlin (pramlintide) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 1.5ml pen-injector
Table 3. Key Players of 2.7ml pen-injector
Table 4. Global Symlin (pramlintide) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Symlin (pramlintide) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Symlin (pramlintide) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Symlin (pramlintide) Market Share by Regions (2016-2021)
Table 8. Global Symlin (pramlintide) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Symlin (pramlintide) Market Share by Regions (2022-2027)
Table 10. Symlin (pramlintide) Market Trends
Table 11. Symlin (pramlintide) Market Drivers
Table 12. Symlin (pramlintide) Market Challenges
Table 13. Symlin (pramlintide) Market Restraints
Table 14. Global Symlin (pramlintide) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Symlin (pramlintide) Market Share by Players (2016-2021)
Table 16. Global Top Symlin (pramlintide) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Symlin (pramlintide) as of 2020)
Table 17. Ranking of Global Top Symlin (pramlintide) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Symlin (pramlintide) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Symlin (pramlintide) Product Solution and Service
Table 21. Date of Enter into Symlin (pramlintide) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Symlin (pramlintide) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Symlin (pramlintide) Revenue Market Share by Type (2016-2021)
Table 25. Global Symlin (pramlintide) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Symlin (pramlintide) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Symlin (pramlintide) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Symlin (pramlintide) Revenue Market Share by Application (2016-2021)
Table 29. Global Symlin (pramlintide) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Symlin (pramlintide) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Symlin (pramlintide) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Symlin (pramlintide) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Symlin (pramlintide) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Symlin (pramlintide) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Symlin (pramlintide) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Symlin (pramlintide) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Symlin (pramlintide) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Symlin (pramlintide) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Symlin (pramlintide) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Symlin (pramlintide) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Symlin (pramlintide) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Symlin (pramlintide) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Symlin (pramlintide) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Symlin (pramlintide) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Symlin (pramlintide) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Symlin (pramlintide) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Symlin (pramlintide) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Symlin (pramlintide) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Symlin (pramlintide) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Symlin (pramlintide) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Symlin (pramlintide) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Symlin (pramlintide) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Symlin (pramlintide) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Symlin (pramlintide) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Symlin (pramlintide) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Symlin (pramlintide) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Symlin (pramlintide) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Symlin (pramlintide) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Symlin (pramlintide) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Symlin (pramlintide) Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Symlin (pramlintide) Product
Table 64. AstraZeneca Revenue in Symlin (pramlintide) Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Symlin (pramlintide) Market Share by Type: 2020 VS 2027
Figure 2. 1.5ml pen-injector Features
Figure 3. 2.7ml pen-injector Features
Figure 4. Global Symlin (pramlintide) Market Share by Application: 2020 VS 2027
Figure 5. Type I diabetes Case Studies
Figure 6. Type II diabetes Case Studies
Figure 7. Symlin (pramlintide) Report Years Considered
Figure 8. Global Symlin (pramlintide) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Symlin (pramlintide) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Symlin (pramlintide) Market Share by Regions: 2020 VS 2027
Figure 11. Global Symlin (pramlintide) Market Share by Regions (2022-2027)
Figure 12. Global Symlin (pramlintide) Market Share by Players in 2020
Figure 13. Global Top Symlin (pramlintide) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Symlin (pramlintide) as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Symlin (pramlintide) Revenue in 2020
Figure 15. Global Symlin (pramlintide) Revenue Market Share by Type (2016-2021)
Figure 16. Global Symlin (pramlintide) Revenue Market Share by Type (2022-2027)
Figure 17. North America Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Symlin (pramlintide) Market Share by Type (2016-2027)
Figure 19. North America Symlin (pramlintide) Market Share by Application (2016-2027)
Figure 20. North America Symlin (pramlintide) Market Share by Country (2016-2027)
Figure 21. United States Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Symlin (pramlintide) Market Share by Type (2016-2027)
Figure 25. Europe Symlin (pramlintide) Market Share by Application (2016-2027)
Figure 26. Europe Symlin (pramlintide) Market Share by Country (2016-2027)
Figure 27. Germany Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Symlin (pramlintide) Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Symlin (pramlintide) Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Symlin (pramlintide) Market Share by Region (2016-2027)
Figure 37. China Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Symlin (pramlintide) Market Share by Type (2016-2027)
Figure 45. Latin America Symlin (pramlintide) Market Share by Application (2016-2027)
Figure 46. Latin America Symlin (pramlintide) Market Share by Country (2016-2027)
Figure 47. Mexico Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Symlin (pramlintide) Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Symlin (pramlintide) Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Symlin (pramlintide) Market Share by Country (2016-2027)
Figure 53. Turkey Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Symlin (pramlintide) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in Symlin (pramlintide) Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

---